Lopinavir/Ritonavir Monotherapy as a Nucleoside Analogue–Sparing Strategy to Prevent HIV-1 Mother-to-Child Transmission: The ANRS 135 PRIMEVA Phase 2/3 Randomized Trial - Concepedia

Concepedia

Publication | Open Access

Lopinavir/Ritonavir Monotherapy as a Nucleoside Analogue–Sparing Strategy to Prevent HIV-1 Mother-to-Child Transmission: The ANRS 135 PRIMEVA Phase 2/3 Randomized Trial

DOI Full Paper Access

25

Citations

31

References

2013

Year

Roland Tubiana, Laurent Mandelbrot, Jérôme Le Chenadec, Sandrine Delmas, Christine Rouzioux, Déborah Hirt, Jean‐Marc Tréluyer, Dieudonné Ekoukou, E Bui, Marie‐Laure Chaix,

Clinical Infectious Diseases

Abstract

LPV/r monotherapy achieved satisfactory virologic efficacy in women treated solely for PMTCT, providing proof of concept for future nucleoside-sparing strategies.

References

	Year	Citations

Page 1